Fluorescence Detection-Based Functional Assay for High-Throughput Screening for MraY

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 3, 2004, Pages 897-902

  Stachyra, Thérèse ^a   Dini, Christophe ^a   Ferrari, Paul ^a   Bouhss, Ahmed ^b   Van Heijenoort, Jean ^b   Mengin Lecreulx, Dominique ^b   Blanot, Didier ^b   Biton, Jacques ^a   Le Beller, Dominique ^a  

^a SANOFI   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BACTERIAL PROTEIN; ENZYME INHIBITOR; MUREIDOMYCIN B; PEPTIDOGLYCAN; PROTEIN MRAY; RU 64957; RU 66950; RU 70157; RU 72143; RU 72839; RU 74709; RU 74854; RU 75413; RU 76491; RU 76492; RU 77254; RU 78695; RU 80303; RU 88108; RU 88110; RU 88114; RU 88155; TUNICAMYCIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLMURAMIC ACID;

ARTICLE; BACTERIAL CELL WALL; ENZYME INHIBITION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DANSYL COMPOUNDS; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MONOSACCHARIDES; OLIGOPEPTIDES; PLASMIDS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TRANSFERASES;

EID: 1442349130     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.3.897-902.2004     Document Type: Article

References (30)

1. Auger, G., M. Crouvoisier, M. Caroff, J. van Heijenoort, and D. Blanot. 1997. Synthesis of an analogue of the lipoglycopeptide membrane intermediate I of peptidoglycan biosynthesis. Lett. Peptide Sci. 4:371-376.
2. Auger, G., J. van Heijenoort, D. Mengin-Lecreulx, and D. Blanot. 2003. A MurG assay which utilizes a synthetic analogue of lipid I. FEMS Microbiol. Lett. 219:115-119.
3. Barbosa, M. D. F. S., H. O. Ross, M. C. Hillman, R. P. Meade, M. G. Kurilla, and D. L. Pompliano. 2002. A multitarget assay for inhibitors of membrane-associated steps of peptidoglycan biosynthesis. Anal. Blochem. 306:17-22.
4. Bouhss, A., D. Mengin-Lecreulx, D. Le Beller, and J. van Heijenoort. 1999. Topological analysis of the MraY protein catalysing the first membrane step of peptidoglycan synthesis. Mol. Microbiol. 34:576-585.
5. Boyle, D. S., and W. D. Donachie. 1998. mraY is an essential gene for cell growth in Escherichia coli. J. Bacteriol. 180:6429-6432.
6. Brandish, P. E., M. K. Burnham, J. T. Lonsdale, R. Southgate, M. Inukai, and T. D. H. Bugg. 1996. Slow binding inhibition of phospho-N-acetylmuramyl-pentapeptide-translocase (Escherichia coli) by mureidomycin A. J. Biol. Chem. 271:7609-7614.
7. Brandish, P. E., K. I. Kimura, M. Inukai, R. Southgate, J. T. Lonsdale, and T. D. H. Bugg. 1996. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli. Antimicrob. Agents Chemother. 40:1640-1644.
8. Brandstrom, A. A., S. Midha, C. B. Longley, K. Han, E. R. Baizman, and H. R. Axelrod. 2000. Assay for identification of inhibitors for bacterial MraY translocase or MurG transferase. Anal. Biochem. 280:315-319.
9. Bugg, T. D. H., and P. E. Brandish. 1994. From peptidoglycan to glycoproteins: common features of lipid-linked oligosaccharide biosynthesis. FEMS Microbiol. Lett. 119:255-262.
10. Cartwright, S. J., and S. G. Waley. 1984. Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose. Biochem. J. 221: 505-512.
11. Chandrakala, B., B. C. Elias, U. Mehra, N. S. Umapathy, P. Dwarakanath, T. S. Balganesh, and S. M. deSousa. 2001. Novel scintillation proximity assay for measuring membrane-associated steps of peptidoglycan biosynthesis in Escherichia coli. Antimicrob. Agents Chemother. 45:768-775.
12. Dagert, M., and S. D. Ehrlich. 1979. Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells. Gene 6:23-28.
13. Dini, C., P. Collette, N. Drochon, J. C. Guillot, G. Lemoine, P. Mauvais, and J. Aszodi. 2000. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors. Bioorg. Med. Chem. Lett. 10:1839-1843.
14. Dini, C., S. Didier-Laurent, N. Drochon, S. Feteanu, J. C. Guillot, F. Monti, E. Uridat, J. Zhang, and J. Aszodi, 2002. Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure. Bioorg. Med. Chem. Lett. 12:1209-1213.
15. Dini, C., N. Drochon, S. Feteanu, J. C. Guillot, C. Peixoto, and J. Aszodi. 2001. Synthesis of analogues of the O-β-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1. Contribution of the amino group and the uracil moiety upon the inhibition of MraY. Bioorg. Med. Chem. Lett. 11:529-531.
16. Dini, C., N. Drochon, J. C. Guillot, P. Mauvais, P. Walter, and J. Aszodi. 2001. Synthesis of analogues of the O-β-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 2: role of the hydroxyl groups upon the inhibition of MraY. Bioorg. Med. Chem. Lett. 11:533-536.
17. Hyland, S. A., and M. S. Anderson. 2003. A high-throughput solid-phase extraction assay capable of measuring diverse polyprenyl phosphate: sugar-1-phosphate transferases as exemplified by the WecA, MraY, and MurG proteins. Anal. Biochem. 317:156-164.
18. Inukai, M., F. Ishino, and A. Takaitsuld. 1993. Selective inhibition of the bacterial translocase reaction in peptidoglycan synthesis by mureidomycins. Antimicrob. Agents Chemother. 37:980-983.
19. Loubens, L., L. Debardieux, A. Bohin, J.-M. Lacroix, and J.-P. Bohin. 1993. Homology between a genetic locus (mdoA) involved in the osmoregulated biosynthesis of periplasmic glucans in Escherichia coli and a genetic locus (hrpM) controlling the pathogenicity of Pseudomonas syringae. Mol. Microbiol. 10:329-340.
20. Lugtenberg, E. J. J., A. van SchUndel-van Dam, and T. H. M. van Bellegem. 1971. In vivo and in vitro action of new antibiotics interfering with the utilization of N-acetyl-glucosamine-N-acetyl-muramyl-pentapeptide. J. Bacteriol. 108:20-29.
21. Maass, D., and H. Pelzer. 1981. Murein biosynthesis in ether permeabilized Escherichia coli starting from early peptidoglycan precursors. Arch. Microbiol. 130:301-306.
22. McDonald, L. A., L. R. Barbieri, G. T. Carter, E. Lenoy, J. Lotvin, P. J. Petersen, M. M. Siegel, G. Singh, and R. T. Williamson. 2002. Structures of the muraymycins, novel peptidogiycan biosynthesis inhibitors. J. Am. Chem. Soc. 124:10260-10261.
23. Neuhaus, F. C. 1971. Initial translocation reaction in the biosynthesis of peptidoglycan by bacterial membranes. Acc. Chem. Res. 4:297-303.
24. Reddy, S. G., S. T. Waddell, D. W. Kuo, K. K. Wong, and D. L. Pompliano. 1999. Preparative enzymatic synthesis and characterization of the cytoplasmic intermediates of murein biosynthesis. J. Am. Chem. Soc. 121:1175-1178.
25. Riesenberg, D., V. Schulz, W. A. Knorre, H. D. Pohl, D. Korz, E. A. Sanders, A. Ross, and W. D. Deckwer. 1991. High cell density cultivation of Escherichia coli at controlled specific growth rate. J. Biotechnol. 20:17-28.
26. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
27. Somner, E. A., and P. E. Reynolds. 1990. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob. Agents Chemother. 34:423-429.
28. van Heijenoort, J. 2001. Recent advances in the formation of bacterial peptidoglycan monomer unit. Nat. Prod. Rep. 18:503-519.
29. ε-5-dimethylaminonaphthalene-1-sulfonyl)pentapeptide. J. Biol. Chem. 252:2296-2303.
30. Zawadzke, L E., W. Ping, L Cook, L. Fan, M. Casperson, M. Kishnani, D. Calambur, S. J. Hofstead, and R. Padmanabha. 2003. Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention. Anal. Biochem. 314:243-252.